Virtus Biotech ETF (BBP) is a publicly traded company in the Financial Services sector, operating within the Asset Management industry.
BBP has IPO date of 2014-12-17, listed on the NYSE, a market capitalization of $35.48M.
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index, which tracks the performance of biotechnology companies with at least one drug therapy approved by the FDA.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Products ETF to Virtus Biotech ETF.
